TCIM
FLNA

TIAA CREF Investment Management’s Filana Therapeutics FLNA Stock Holding History

TIAA CREF Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,009
Closed -$85K – 3132
2015
Q2 		$85K Sell
7,009
-11,814
-63% -$162K ﹤0.01% 3169
2015
Q1 		$249K Hold
18,823
– – ﹤0.01% 3036
2014
Q4 		$267K Sell
18,823
-479
-2% -$8.29K ﹤0.01% 3067
2014
Q3 		$528K Hold
19,302
– – ﹤0.01% 2951
2014
Q2 		$777K Buy
+19,302
New +$714K ﹤0.01% 2866
2013
Q3 		– Sell
-783
Closed -$12K – 3107
2013
Q2 		$12K Buy
+783
New +$16.6K ﹤0.01% 3081

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TIAA CREF Investment Management's FLNA Position: Q3 2015 in Review

TIAA CREF Investment Management sold out of Filana Therapeutics (FLNA) in Q3 2015, closing a stake of 7,009 shares — an estimated $85K sold.

TIAA CREF Investment Management first reported a position in FLNA in Q2 2013 and held it in 6 quarters. The position peaked at $777K in Q2 2014. 49 funds tracked by Wall St. Rank hold FLNA as of Q3 2015.

  • TIAA CREF Investment Management reported no remaining Filana Therapeutics position as of Q3 2015 after selling out during the quarter.
  • TIAA CREF Investment Management sold 7,009 Filana Therapeutics shares in Q3 2015, an estimated $85K.
  • TIAA CREF Investment Management first reported a position in Filana Therapeutics in Q2 2013 and held it in 6 quarters.
  • TIAA CREF Investment Management's Filana Therapeutics position peaked at $777K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2015.

Based on TIAA CREF Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.